Grasp Bioscience AB is a Swedish AB based in Järfälla, operating in the Engineering activities and related technical consultancy sector. Incorporated in 1998, the company has 0 employees and reported revenue of SEK 69.7k in its latest annual filing.
Bolaget skall bedriva konsulttjänster inom affärs- och marknadsutveckling inom bioteknik, värdepapperhantering samt bedriva därmed förenlig verksamhet. Bolaget skall även bedriva verksamhet med musik-, TV- och filmproduktion och distribution av musik och media samt därmed förenlig verksamhet.
In its most recent annual report (2025), Grasp Bioscience AB reported revenue of SEK 69.7k, a decrease of 64% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 157.4k, and the EBITDA margin stood at -814.5%.
At the end of 2025, equity financed 83.9% of the balance sheet, and current assets covered short-term debt 3 times.
Frequently asked questions
What is the Org number of Grasp Bioscience AB?
Grasp Bioscience AB is registered with Bolagsverket / SCB under Org 5565625810.
What is the revenue of Grasp Bioscience AB?
Grasp Bioscience AB reported revenue of SEK 69.7k in 2025.
Who is the CEO of Grasp Bioscience AB?
Anna Carina Schmidt is the CEO of Grasp Bioscience AB, in role since 2022.
Where is Grasp Bioscience AB headquartered?
Grasp Bioscience AB's registered address is Kärrvägen 35.
